Serological Analysis to Delineate Between Gastric Atrophy and a Normal Health Stomach without Endoscopy
Abstract:
The article
"Serological Assessment of Samples from Patients Complaining of Dyspepsia"
by Dr. Stephen Mortlock is current article published in the Journal of
Gastrointestinal and Digestive Systems in October 2013. This review analyses
the article's structure, authority, currency, stability, objectivity and it
relevance to students and the health care industry. The review first summarize
the article. it then analysis the structure of the article, taking into
consideration the concept, methodology of the research, it accessible and the
technical flow of the article. The review will also critique the article on the
basis of its authority, currency, accuracy, objectivity and it stability. The
relevance of the article to in the academia and healthcare industry will also
be analyzed in the review. The review will analyze all the relevant data and
information (including diagrams) provided by the article before judging on the
credibility and the reliability of the article. In entirety, the article is
very well written, well structured, clear and relevant in to first year medical
students and general practitioners.
References:
[1.] Agréus, L., Kuipers, EJ., Kupcinskas, L.,
Malfertheiner, P., & Di Mario, F., et al (2012). Rationale in diagnosis and
screening of atrophic gastritis with stomach-specific plasma biomarkers. Scand
J Gastroenterol 47: 136-147.
[2.] Agréus, L., Kuipers, EJ., Kupcinskas, L.,
Malfertheiner, P., & Di Mario, F., et al. (2012). Rationale in diagnosis
and screening of atrophic gastritis with stomach-specific plasma biomarkers.
Scand J Gastroenterol 47: 136-147.
[3.] Axon, A.,(2002) Management of uninvestigated
dyspepsia: review and commentary. Gut 50 Suppl 4: iv51-55.
[4.] Brun, R., & Kuo, B., (2010). Functional dyspepsia.
Therap Adv Gastroenterol 3: 145-164.
[5.] Dai, YC., Tang, ZP.,& Zhang ,YL (2011). How to
assess the severity of atrophic gastritis. World J Gastroenterol 17:
1690-1693.
[6.] ErdoÄŸan, A.,& Yilmaz, U., (2011). Is there a
relationship between Helicobacter pylori and gastric autoimmunity? Turk J Gastroenterol
22: 134-138.
[7.] Harmon, RC., & Peura, DA., (2010). Evaluation and
management of dyspepsia. Therap Adv Gastroenterol 3: 87-98.
[8.] Iijima, K., Abe, Y., Kikuchi, R., Koike, T., &
Ohara, S., et al. (2009). Serum biomarker tests are useful in delineating
between patients with gastric atrophy and normal, healthy stomach. World J Gastroenterol
15: 853-859.
[9.] Kamangar, F., Sheikhattari, P., & Mohebtash, M.,
(2011). Helicobacter pylori and its effects on human health and disease. Arch
Iran Med 14: 192-199.
[10.] Mason, JM., Delaney, B., Moayyedi, P., Thomas,
M.,& Walt, R., et al. (2005). Managing dyspepsia without alarm signs in
primary care: new national guidance for England and Wales. Aliment Pharmacol
Ther 21: 1135-1143.
[11.] Mortlock, S., Nikulin, M., & Arnold-Maclean, C.,
(2012). ‘External quality assessment of a non-standard gastric assay panel.’
The Biomedical Scientist 56: 533-534.
[12.] Nasrollahzadeh, D., Aghcheli, K., Sotoudeh, M.,
Shakeri, R., & Persson,EC., et al. (2011). Accuracy and cut-off values of
pepsinogens I, II and gastrin 17 for diagnosis of gastric fundic atrophy:
influence of gastritis. PLoS One 6: e26957.
[13.] Oustamanolakis, P.,& Tack, J., (2012). Dyspepsia:
organic versus functional. J Clin Gastroenterol 46: 175-190.
[14.] Penston, JG., & Pounder, RE., (1996). A survey of
dyspepsia in Great Britain. Aliment Pharmacol Ther 10: 83-89.
[15.] Spiegel, BM., Vakil, NB., & Ofman, JJ., (2002)
Dyspepsia management in primary care: a decision analysis of competing
strategies. Gastroenterology 122: 1270-1285.
[16.] Sudraba, A., Daugule, I., Rudzite, D., Funka, K.,
& Tolmanis, I., et al. (2011). Performance of routine Helicobacter pylori
tests in patients with atrophic gastritis. J Gastrointestin Liver Dis 20:
349-354.
[17.] Sugano, K .,(2011). Should we still subcategorize helicobacter
pylori-associaed dyspepsia as functional disease? J Neurogastroenterol Motil
17: 366-371.
[18.] Taniyama, K., Shimbo, T., Iwase, H., Tanaka, S., &
Watanabe, N., et al. (2011). Evidence-based therapy according to the guideline
for gastric ulcers is cost-effective in Japan. J Physiol Pharmacol 62:
627-635.
[19.] Wallander, MA., Johansson, S., Ruigómez, A., García Rodríguez,
LA., & Jones, R., (2007). Dyspepsia in general practice: incidence, risk
factors, comorbidity and mortality. Fam Pract 24: 403-411.
[20.] Yakoob, J., Abbas, Z., Khan, R., Naz, S., & Ahmad,
Z., et al. (2012). Prevalence of non Helicobacter pylori species in patients
presenting with dyspepsia. BMC Gastroenterol 12: 3.